USD 10.08
(0.6%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 109.22 Million USD | 9.39% |
2022 | 89.59 Million USD | 34.45% |
2021 | 66.63 Million USD | 42.59% |
2020 | 46.73 Million USD | 18.75% |
2019 | 39.35 Million USD | 47.51% |
2018 | 26.67 Million USD | 8.42% |
2017 | 24.6 Million USD | -15.39% |
2016 | 29.08 Million USD | 43.06% |
2015 | 20.33 Million USD | 212.95% |
2014 | 6.49 Million USD | 84.99% |
2013 | 3.51 Million USD | 15.47% |
2012 | 3.04 Million USD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 27.49 Million USD | 13.85% |
2024 Q1 | 24.14 Million USD | -2.16% |
2023 FY | 98 Million USD | 9.39% |
2023 Q3 | 26.86 Million USD | -0.29% |
2023 Q4 | 24.68 Million USD | -8.12% |
2023 Q1 | 26.43 Million USD | 10.7% |
2023 Q2 | 26.94 Million USD | 1.9% |
2022 Q4 | 23.88 Million USD | 3.32% |
2022 Q1 | 20.29 Million USD | 4.91% |
2022 Q2 | 22.06 Million USD | 8.74% |
2022 Q3 | 23.11 Million USD | 4.75% |
2022 FY | 89.59 Million USD | 34.45% |
2021 Q1 | 13.74 Million USD | 11.58% |
2021 FY | 66.63 Million USD | 42.59% |
2021 Q2 | 16.19 Million USD | 17.78% |
2021 Q3 | 17.35 Million USD | 7.2% |
2021 Q4 | 19.34 Million USD | 11.46% |
2020 Q1 | 11.4 Million USD | 4.62% |
2020 Q2 | 11.01 Million USD | -3.38% |
2020 Q3 | 11.99 Million USD | 8.85% |
2020 FY | 46.73 Million USD | 18.75% |
2020 Q4 | 12.31 Million USD | 2.73% |
2019 Q4 | 10.9 Million USD | 2.55% |
2019 Q2 | 9.4 Million USD | 11.6% |
2019 Q1 | 8.42 Million USD | 21.49% |
2019 FY | 39.35 Million USD | 47.51% |
2019 Q3 | 10.62 Million USD | 13.06% |
2018 Q3 | 6.82 Million USD | 7.41% |
2018 FY | 26.67 Million USD | 8.42% |
2018 Q4 | 6.93 Million USD | 1.59% |
2018 Q2 | 6.35 Million USD | -3.19% |
2018 Q1 | 6.56 Million USD | 6.32% |
2017 Q1 | 6.1 Million USD | -15.72% |
2017 FY | 24.6 Million USD | -15.39% |
2017 Q4 | 6.17 Million USD | 1.15% |
2017 Q3 | 6.1 Million USD | -2.0% |
2017 Q2 | 6.22 Million USD | 2.1% |
2016 Q1 | 7.01 Million USD | 7.37% |
2016 FY | 29.08 Million USD | 43.06% |
2016 Q4 | 7.23 Million USD | -2.17% |
2016 Q3 | 7.39 Million USD | -0.51% |
2016 Q2 | 7.43 Million USD | 6.08% |
2015 Q1 | 3.87 Million USD | 60.51% |
2015 Q3 | 5.44 Million USD | 21.48% |
2015 Q2 | 4.48 Million USD | 15.55% |
2015 Q4 | 6.52 Million USD | 19.96% |
2015 FY | 20.33 Million USD | 212.95% |
2014 FY | 6.49 Million USD | 84.99% |
2014 Q1 | 1.13 Million USD | 14.15% |
2014 Q4 | 2.41 Million USD | 56.72% |
2014 Q2 | 1.38 Million USD | 21.68% |
2014 Q3 | 1.54 Million USD | 11.16% |
2013 Q3 | 792.28 Thousand USD | 0.0% |
2013 Q4 | 998.39 Thousand USD | 26.01% |
2013 FY | 3.51 Million USD | 15.47% |
2012 FY | 3.04 Million USD | 0.0% |
2001 Q3 | 17.35 Million USD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Acadia Healthcare Company, Inc. | 176.01 Million USD | 37.946% |
Addus HomeCare Corporation | 248.92 Million USD | 56.121% |
AirSculpt Technologies, Inc. | 118.32 Million USD | 7.69% |
Amedisys, Inc. | 834.47 Million USD | 86.911% |
American Oncology Network, Inc. | 83.97 Million USD | -30.066% |
Astrana Health, Inc. | 112.59 Million USD | 2.997% |
Aveanna Healthcare Holdings Inc. | 587.36 Million USD | 81.404% |
IMAC Holdings, Inc. | 5.02 Million USD | -2072.671% |
biote Corp. | 98.82 Million USD | -10.52% |
Cryo-Cell International, Inc. | 35.2 Million USD | -210.245% |
Cross Country Healthcare, Inc. | 337.69 Million USD | 67.657% |
COMPASS Pathways plc | 136.91 Million USD | 20.228% |
DocGo Inc. | 180.32 Million USD | 39.431% |
The Ensign Group, Inc. | 335.39 Million USD | 67.434% |
Healthcare Services Group, Inc. | 189.09 Million USD | 42.238% |
InnovAge Holding Corp. | 558.25 Million USD | 80.435% |
Assure Holdings Corp. | 15.43 Million USD | -607.448% |
LifeStance Health Group, Inc. | 491.23 Million USD | 77.765% |
Mobile-health Network Solutions Class A Ordinary Shares | 18.24 Million USD | -498.74% |
ModivCare Inc. | 586.89 Million USD | 81.39% |
NewGenIvf Group Limited | 1.63 Million USD | -6561.788% |
Novo Integrated Sciences, Inc. | 13.5 Million USD | -708.706% |
Option Care Health, Inc. | 666.62 Million USD | 83.616% |
P3 Health Partners Inc. | 199.56 Million USD | 45.27% |
P3 Health Partners Inc. | 199.56 Million USD | 45.27% |
The Pennant Group, Inc. | 88.99 Million USD | -22.729% |
Surgery Partners, Inc. | 319.5 Million USD | 65.814% |
Syra Health Corp. Class A Common Stock | 4.29 Million USD | -2440.363% |
Talkspace, Inc. | 97.58 Million USD | -11.921% |
Talkspace, Inc. | 97.58 Million USD | -11.921% |
The Oncology Institute, Inc. | 136.59 Million USD | 20.037% |
The Oncology Institute, Inc. | 136.59 Million USD | 20.037% |